Riskpilot← Back to searchSign inGet full accessALFA RØNTGEN AS
ASActiveOrg 996401960Sandsværveien 228, 3615 KongsbergDiagnostic imaging services and medical laboratory activities · NACE 8691Est. 201125 employeeswww.helsehuset.kongsberg.no
Revenue 2025
NOK 43,7M
+7% vs 2024
EBITDA margin
4.0%
+167% vs 2024
Equity ratio
49.3%
Financial strength
Net profit 2025
NOK 642K
+461% vs 2024
| Revenue | NOK 43,7M | +7% |
| EBITDA | NOK 1,7M | +167% |
| Net profit | NOK 642K | +461% |
| Total assets | NOK 16,4M | -6% |
| Equity | NOK 8,1M | +9% |
| Employees | 25 | — |
Legal name
ALFA RØNTGEN AS
Org number
996401960
Legal form
Aksjeselskap
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
11. januar 2011
Share capital
NOK 820 000
Employees
25 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Salg av helsetjenester, samt deltakelse i andre selskap.
Address
Sandsværveien 228, 3615 Kongsberg
Website
www.helsehuset.kongsberg.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 400 | 15 137 | 7 043 | 4 173 | 3 427 | 12 755 | 14 390 | 14 964 | 15 939 | 15 054 | 22 547 | 34 830 | 39 891 | 40 677 | 43 705 |
| Staff expenses | −2 891 | −6 960 | −4 809 | −1 299 | −1 017 | −5 907 | −6 511 | −6 148 | −6 599 | −7 000 | −12 324 | −18 939 | −19 618 | −21 876 | −22 789 |
| EBITDA | −1 550 | 339 | −4 628 | −1 300 | −715 | 1 733 | 1 894 | 1 843 | 2 269 | 960 | −892 | 1 273 | 2 613 | 648 | 1 731 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −63 | −108 | −145 | −745 | −819 |
| EBIT | −1 550 | 339 | −4 628 | −1 300 | −715 | 1 733 | 1 894 | 1 843 | 2 269 | 960 | −955 | 1 165 | 2 468 | −96 | 912 |
| Net financials | −65 | 0 | 0 | −1 | 1 | 1 | 0 | 0 | 0 | −26 | −51 | −36 | −23 | −132 | −88 |
| Profit before tax | −1 615 | 339 | −4 628 | −1 302 | −714 | 1 734 | 1 895 | 1 844 | 2 269 | 934 | −1 006 | 1 129 | 2 445 | −228 | 824 |
| Tax | −0 | −0 | −0 | −0 | −0 | −1 486 | 498 | 449 | 511 | 206 | −221 | 248 | 540 | −50 | 181 |
| Net profit | −1 615 | 339 | −4 628 | −1 302 | −714 | 3 220 | 1 397 | 1 395 | 1 758 | 729 | −785 | 881 | 1 905 | −178 | 642 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 306 | 2 529 | 942 | 224 | 797 | 4 955 | 7 228 | 8 089 | 9 622 | 10 167 | 11 073 | 12 512 | 15 242 | 17 388 | 16 365 |
| Equity | 185 | 524 | −1 704 | −205 | 281 | 3 501 | 4 898 | 6 293 | 6 051 | 6 106 | 5 321 | 6 078 | 6 014 | 7 431 | 8 073 |
| Long-term debt | 95 | 0 | 1 575 | 0 | 0 | 0 | 0 | 0 | 0 | 1 500 | 900 | 481 | 280 | 1 485 | 1 256 |
| Short-term debt | 1 026 | 2 005 | 1 070 | 429 | 515 | 1 454 | 2 330 | 1 796 | 3 572 | 2 561 | 4 852 | 5 953 | 8 948 | 8 472 | 7 036 |
| Total debt | 1 121 | 2 005 | 2 645 | 429 | 515 | 1 454 | 2 330 | 1 796 | 3 572 | 4 061 | 5 752 | 6 434 | 9 228 | 9 957 | 8 292 |
EBITDA margin
4.0%
This company
15.8%
Market median
-75% vs market
20112025
Equity ratio
49.3%
This company
38.2%
Market median
+29% vs market
20112025
Return on equity
8.0%
This company
18.4%
Market median
-57% vs market
20112025
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20112025
Asset turnover
2.67×
This company
1.12×
Market median
+138% vs market
20112025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20112025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SH Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Helsehuset Holding As | Company | 100.0% | 100.0% | 2023 |
Seljord Invest As | Company | 23.0% | 23.0% | 2024 |
| Individual | 21.7% | 21.7% | 2024 | |
Dyrud Eigedom As | Company | 14.1% | 14.1% | 2024 |
Gulhaugen Holding As | Company | 3.9% | 3.9% | 2024 |
| Individual | 3.5% | 3.5% | 2024 | |
| Individual | 1.8% | 1.8% | 2024 | |
| Individual | 1.2% | 1.2% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ALFA RØNTGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svein Hagen | Chief Executive Officer | 0 companies |
| Hans Olav Omtveit | Board of Directors | 0 companies |
| Morten Olav Dyrud | Board of Directors | 0 companies |
| Ole Edvard Hagen | Board of Directors | 0 companies |